BRIAN COOK: Open Payments
NPI 1932381696 · PROSPER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,039 in 76 payments from 20 companies in 2025. Trend: 2023 $1,513 · 2024 $3,958 · 2025 $2,039
Food & beverage: $2,039
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $355 |
| Incyte Corporation | 8 | $323 |
| Arcutis Biotherapeutics, Inc. | 5 | $200 |
| GENZYME CORPORATION | 2 | $158 |
| E.R. Squibb & Sons, L.L.C. | 10 | $153 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $114 |
| Almirall LLC | 4 | $106 |
| LEO Pharma Inc. | 4 | $95 |
| PFIZER INC. | 4 | $72 |
Products named: OPZELURA, Zoryve, DUPIXENT, Sotyktu, RINVOQ, SKYRIZI, Cabtreo, BOTOX.
Industry payments across TX — which companies pay providers there.
